Medtronic has recalled 686 TurboHawk Plus Directional Atherectomy Systems because there is a risk that the guidewire within the catheter may move downward or prolapse during use, which may damage the ...
Medtronic and the FDA are expanding the reach of a Class I recall handed down in January for the medtech giant’s catheter designed to clear out clogged arteries. The previous recall covered more than ...
Editor's note: In an earlier version of this story, TurboHawk was misspelled. MD+DI regrets the error. Earlier this year, Medtronic recalled its HawkOne Directional ...
"Directional atherectomy is an established treatment modality for patients with complex PAD to restore patency, maximize luminal gain and preserve future treatment options," said Professor Thomas ...
Largest directional atherectomy study with independent, core lab analysis demonstrates high limb salvage in patients with critical limb ischemia and strong patency rates in both diabetic and ...
VIVA Physician Sponsored Study to Determine the Benefits of Debulking Plaque and Maximizing Luminal Gain Prior to Drug Coated Balloon Therapy DUBLIN and LAS VEGAS - Nov. 2, 2015 - Medtronic plc (MDT) ...
Expands Treatment Options for Patients in Europe with Peripheral Artery Disease Both Above and Below the Knee DUBLIN - Jan. 24, 2017 - Medtronic plc (NYSE: MDT) today announced CE (Conformité ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback